Brief: Guardant Health Announces Multi-Year Strategic Collaboration Agreement With Merck
19/01/2026 14:32
Jan 19 (Reuters) - Guardant Health Inc GH.O: GUARDANT HEALTH ANNOUNCES MULTI-YEAR STRATEGIC COLLABORATION AGREEMENT WITH MERCK TO DEVELOP COMPANION DIAGNOSTICS AND COMMERCIALIZE NEW CANCER THERAPIES USING GUARDANT INFINITY SMART PLATFORM GUARDANT HEALTH INC - PARTNERSHIP FOR GLOBAL COMMERCIALIZATION OF DRUGS AND COMPANION DIAGNOSTICS IN US, ASIA-PACIFIC, UK, EU MARKETS Source text: ID:nBw9PV542a Further company coverage: GH.O ((Reuters.Briefs@thomsonreuters.com))
Recent news on Guardant Health
See all newsU.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
U.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
U.S. STOCKS ON THE MOVE-Enliven Therapeutics, DXC Technology, Humacyte